Skip to main content
. 2023 Apr 19;45(2):182–195. doi: 10.47626/1516-4446-2022-2876

Table 3. Summary of findings from case series.

Author(s) n Age (years) Sex Palliative care diagnosis Intervention (dose, route, duration) Depression measures Results (depression) Side effects Comments and follow-up
Iglewicz52 31 44-89 Both Multiple (cancer and non-cancer) Single (n=22) or multiple (n=9) doses of 0.5 mg/kg oral (n=29), SC (n=1) or oral + SC (n=1) ketamine CGI score at baseline and days 0-1, 2-3, 4-7, and 8-21 Positive therapeutic outcomes for depression were more common (93%) than negative therapeutic outcomes at days 0-1 (p < 0.001), 2-3 (p < 0.001), and 4-7 (p < 0.05) No serious side effects More patients had positive therapeutic outcomes than negative therapeutic outcomes (p < 0.001 at days 0-1 and 8-21, and p < 0.05 at days 2-3 and 4-7)
Latuga53 3 76 Male Metastatic pancreatic adenocarcinoma A single dose of SC ketamine (0.5 mg/kg) followed by repeated oral ketamine doses (daily, 0.5 mg/kg) PHQ-4 Reduction from PHQ-4 12 at baseline to PHQ-4 0 on day 7 Somnolence, nausea, drowsiness, fatigue, sleepiness, feeling “strange” and “floating” Increased blood pressure at 20 min post-injection in one patient Sustained remission with 0 on PHQ-4, died on day 50
83 Male End-stage alcoholic cirrhosis Reduction on PHQ-4 from 6 at baseline to 1 on day 7 PHQ-4 remained between 1 and 3, died on day 139
49 Female Metastatic ovarian cancer Reduction of PHQ-4 from 12 on day 3 to 1 on day 19 Sustained until she died on day 37
Rosenblat & Li54 3 67 Female Cancer Repeated IM ketamine (three doses, 3 days interval, 50-150 mg) Improved guilt, indecisiveness and strengthened desire for MAiD Transient drowsiness and vivid dreams
60 Female Ovarian cancer Subjective “a lot better,” improved guilt and self-esteem, withdrew request for MAiD Transient drowsiness and dizziness
80 Male Prostate cancer Subjective improvement of depression, improved sleep
Received MAiD
Transient drowsiness and confusion

CGI = Clinical Global Impression; IM = intramuscular; MAiD = medical assistance in dying; PHQ-4 = Patient Health Questionnaire; SC = subcutaneous.